• From Spinal Taps to Blood-Based Biomarkers: Advances in Alzheimer’s Testing

  • Aug 12 2024
  • Duración: 21 m
  • Podcast

From Spinal Taps to Blood-Based Biomarkers: Advances in Alzheimer’s Testing

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • In this edition of Clinical Lab Chat, CLP’s Director of Business Intelligence, Chris Wolski, interviews Alessio Travaglia, PhD, PMP, director, Translational Science, Neuroscience, at the Foundation for the National Institutes of Health (FNIH).

    The wide-ranging interview tackles all aspects of Alzheimer’s testing and treatment, including:

    • Why traditional methods of Alzheimer’s testing are expensive, invasive, and limit access.
    • The benefits of blood-based biomarkers for Alzheimer’s diagnosis.
    • How better diagnostics will benefit patients.
    • Why we’re on the cusp of a new golden age of neurology
    • How more biomarkers fuel not only better diagnostics but better treatments.
    Más Menos
Economía Química
Más Menos

Lo que los oyentes dicen sobre From Spinal Taps to Blood-Based Biomarkers: Advances in Alzheimer’s Testing

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles